GSK3772701

Unknown / undisclosed

Phase 2Mechanism not established

Automated registry profile: compiled from public clinical-trial and regulatory records; not yet individually analyst-verified.

Earlyevidence

Evidence outlook

Mid-stage studies underway, no completed readout

Phase 2 studies are registered but none has completed a readout, so no evidence signal is assigned yet. The first graded signal arrives with a completed confirmatory readout.

How the evidence outlook works ↗

All registered studies

Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.

Phase 2 (1)
Malaria
NCT07545681 · GlaxoSmithKline
2026-10-07 – 2027-10-08 · Malaria, Falciparum
What this study did
Phase 1 (1)
Malaria
NCT07670377 · GlaxoSmithKline
2026-06-26 – 2026-08-24 · Malaria, Falciparum
What this study did

Competitive landscape

This drug's own stage for Malaria: Phase 2. Competitors below are sorted furthest-along first.

DrugStageModalityMechanismEvidence signalReported efficacygraded featured trials
GSK3772701: this drugPhase 2Undisclosed—not yet gradedNo reviewed efficacy summary in this indication
Ganaplacide / LumefantrinePhase 3Small molecule—not yet gradedNo reviewed efficacy summary in this indication
CipargaminPhase 2Small moleculePfATP4not yet gradedNo reviewed efficacy summary in this indication
GSK4024484Phase 1Undisclosed—not yet gradedNo reviewed efficacy summary in this indication
INE963
Phase 1(overall)
Small molecule—not yet gradedNo reviewed efficacy summary in this indication
GSK4425689
—(overall)
UndisclosedCircumsporozoite protein (CSP)not yet gradedNo reviewed efficacy summary in this indication

Upcoming events

(1 total)

Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.

Follow GSK3772701 to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.

Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.

2027 (1)
October 2027 (1)
Phase 2MalariaRecruiting
Est. primary completion 2027-10-08 · NCT07545681 · CT.gov ↗
What to watch

See the full readout calendar ↗